Columbia Laboratories, Inc. (Columbia) is engaged in pharmaceutical development. The Company has developed and brought to market six bioadhesive products, each commercialized through alliances. The Company�s product, CRINONE (progesterone gel), is sold by Actavis in the United States and by Merck Serono in over 60 other countries worldwide. In September 2013, Columbia acquired Molecular Profiles, a CDMO. Through Molecular Profiles, the Company offers formulation, development, manufacturing and analytics capabilities to clients, including multi-national pharmaceutical companies, specialized drug-delivery firms and biotechnology companies.